191 related articles for article (PubMed ID: 33985544)
1. AKT-mediated phosphorylation of Sox9 induces Sox10 transcription in a murine model of HER2-positive breast cancer.
Al-Zahrani KN; Abou-Hamad J; Pascoal J; Labrèche C; Garland B; Sabourin LA
Breast Cancer Res; 2021 May; 23(1):55. PubMed ID: 33985544
[TBL] [Abstract][Full Text] [Related]
2. Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers.
Al-Zahrani KN; Abou-Hamad J; Cook DP; Pryce BR; Hodgins JJ; Labrèche C; Robineau-Charette P; de Souza CT; Bell JC; Auer RC; Ardolino M; Vanderhyden BC; Sabourin LA
Oncogene; 2020 Jun; 39(23):4592-4602. PubMed ID: 32393835
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z
Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042
[TBL] [Abstract][Full Text] [Related]
4. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
5. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
Roovers K; Wagner S; Storbeck CJ; O'Reilly P; Lo V; Northey JJ; Chmielecki J; Muller WJ; Siegel PM; Sabourin LA
Oncogene; 2009 Aug; 28(31):2839-48. PubMed ID: 19525980
[TBL] [Abstract][Full Text] [Related]
6. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Way TD; Kao MC; Lin JK
J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
[TBL] [Abstract][Full Text] [Related]
7. Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1.
Wang H; Liu M; Ye Z; Zhou C; Bi H; Wang L; Zhang C; Fu H; Shen Y; Yang JJ; Hu Y; Chen G
J Neurosci; 2021 Sep; 41(39):8163-8180. PubMed ID: 34385359
[TBL] [Abstract][Full Text] [Related]
8. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
9. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
10. SOX9 and SOX10 control fluid homeostasis in the inner ear for hearing through independent and cooperative mechanisms.
Szeto IYY; Chu DKH; Chen P; Chu KC; Au TYK; Leung KKH; Huang YH; Wynn SL; Mak ACY; Chan YS; Chan WY; Jauch R; Fritzsch B; Sham MH; Lovell-Badge R; Cheah KSE
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2122121119. PubMed ID: 36343245
[TBL] [Abstract][Full Text] [Related]
11. FOXC1 and SOX10 in Estrogen Receptor-Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction.
Li M; Zhou S; Lv H; Cai M; Wan X; Lu H; Shui R; Yang W
Arch Pathol Lab Med; 2024 Apr; 148(4):461-470. PubMed ID: 37406289
[TBL] [Abstract][Full Text] [Related]
12. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
14. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
Ma Z; Parris AB; Xiao Z; Howard EW; Kosanke SD; Feng X; Yang X
J Exp Clin Cancer Res; 2017 Jan; 36(1):6. PubMed ID: 28061785
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas.
Ivanov SV; Panaccione A; Nonaka D; Prasad ML; Boyd KL; Brown B; Guo Y; Sewell A; Yarbrough WG
Br J Cancer; 2013 Jul; 109(2):444-51. PubMed ID: 23799842
[TBL] [Abstract][Full Text] [Related]
16. The LIM domain binding protein 1, Ldb1, has distinct roles in Neu-induced mammary tumorigenesis.
Ahmed S; Pryce BR; Al-Zahrani KN; Sabourin LA
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt A):1590-1597. PubMed ID: 30327200
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells.
Hosonaga M; Arima Y; Sugihara E; Kohno N; Saya H
Cancer Sci; 2014 Jul; 105(7):779-87. PubMed ID: 24754246
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of the SOX10+ subset of HER2+ breast cancer.
Weisman P; Yu Q; Xu J
Ann Diagn Pathol; 2023 Apr; 63():152087. PubMed ID: 36669230
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor Sox10 regulates oligodendroglial Sox9 levels via microRNAs.
Reiprich S; Cantone M; Weider M; Baroti T; Wittstatt J; Schmitt C; Küspert M; Vera J; Wegner M
Glia; 2017 Jul; 65(7):1089-1102. PubMed ID: 28370559
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway.
Zhao Y; Pang W; Yang N; Hao L; Wang L
Int J Oncol; 2018 Dec; 53(6):2715-2726. PubMed ID: 30272349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]